Dashboard Tools Market News Investing Ideas Pricing About Us
Sign Up
Log in
I

Ibersol SGPS SA
ELI:IBS

Watchlist Manager
Ibersol SGPS SA
ELI:IBS
Watchlist
Price: 11 EUR 2.8% Market Closed
Market Cap: €456.6m
Write Note Create Alert Ask AI
Financials Section:
Income Statement Balance Sheet Cash Flow Statement

Balance Sheet

Assets
+
3Y
+11%
5Y
-8%
10Y
+204%
Liabilities
+
3Y
-1%
5Y
-34%
10Y
+277%
Equity
+
3Y
+31%
5Y
+81%
10Y
+147%

Balance Sheet Decomposition
Ibersol SGPS SA

Balance Sheet
Ibersol SGPS SA

Rotate your device to view
Balance Sheet
Currency: EUR
Dec-2001 Dec-2002 Dec-2003 Dec-2004 Dec-2005 Dec-2006 Dec-2007 Dec-2008 Dec-2009 Dec-2010 Dec-2011 Dec-2012 Dec-2013 Dec-2014 Dec-2015 Dec-2016 Dec-2017 Dec-2018 Dec-2019 Dec-2020 Dec-2021 Dec-2022 Dec-2023 Dec-2024
Assets
Cash & Cash Equivalents
5
4
4
6
5
6
13
7
21
29
29
27
14
1
14
40
35
38
38
51
97
237
189
141
Cash
0
0
0
0
0
0
1
1
0
0
1
1
1
1
1
3
0
1
1
1
1
0
1
1
Cash Equivalents
4
4
3
6
5
6
12
7
21
29
28
26
13
0
14
37
35
37
37
50
96
237
188
140
Short-Term Investments
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
7
5
4
13
2
1
1
1
0
Total Receivables
7
8
10
10
8
12
8
12
13
14
9
10
7
0
9
23
20
24
25
18
19
51
26
34
Accounts Receivables
2
2
3
4
2
4
4
5
13
14
9
10
3
0
4
12
10
14
14
7
8
45
16
21
Other Receivables
5
6
7
6
6
9
4
8
0
0
0
0
4
0
5
10
10
10
11
12
11
7
9
12
Inventory
2
2
3
3
3
4
4
4
4
4
4
4
6
0
8
12
12
12
12
12
16
13
13
15
Other Current Assets
1
9
8
6
3
3
3
5
0
0
0
1
2
0
2
5
5
7
8
8
8
5
7
7
Total Current Assets
15
23
24
24
18
25
27
29
38
47
42
42
28
0
33
85
77
85
97
90
141
307
235
197
PP&E Net
47
57
69
72
73
102
114
119
120
121
123
120
132
0
142
178
198
201
538
495
353
220
350
425
PP&E Gross
47
57
69
72
73
102
114
119
120
121
123
120
132
0
142
178
198
201
538
495
353
0
0
0
Accumulated Depreciation
14
21
25
31
39
60
69
77
81
87
94
100
111
0
117
194
216
236
293
367
343
0
0
0
Intangible Assets
9
8
8
6
5
20
21
19
19
18
16
17
13
0
11
37
35
36
36
37
36
27
27
41
Goodwill
6
10
10
12
13
41
44
44
42
43
43
43
41
0
41
93
93
91
88
81
79
54
54
59
Note Receivable
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Long-Term Investments
9
1
4
2
2
2
0
0
1
1
1
1
3
0
10
13
20
18
6
4
5
20
16
17
Other Long-Term Assets
0
8
0
0
2
2
2
2
3
2
3
3
2
0
5
15
6
13
12
23
19
24
31
22
Other Assets
6
10
10
12
13
41
44
44
42
43
43
43
41
0
41
93
93
91
88
81
79
54
54
59
Total Assets
86
N/A
107
+25%
114
+6%
116
+1%
114
-1%
192
+68%
208
+9%
213
+2%
222
+5%
232
+5%
228
-2%
224
-2%
220
-2%
0
N/A
241
N/A
421
+75%
430
+2%
444
+3%
777
+75%
729
-6%
632
-13%
653
+3%
712
+9%
761
+7%
Liabilities
Accounts Payable
12
15
16
17
26
32
41
34
37
31
22
22
24
27
32
48
68
58
58
45
52
66
55
59
Accrued Liabilities
8
5
5
7
0
0
0
0
0
0
8
9
7
9
10
17
0
17
18
17
15
23
25
22
Short-Term Debt
0
5
0
0
4
36
20
1
7
0
1
1
0
0
0
2
0
6
4
0
0
0
0
1
Current Portion of Long-Term Debt
15
18
8
11
5
11
12
38
25
13
13
17
15
0
18
35
33
53
98
94
54
45
56
89
Other Current Liabilities
12
16
18
16
9
8
13
15
15
21
14
11
10
0
10
21
19
13
15
12
15
10
13
15
Total Current Liabilities
46
59
47
50
43
87
85
88
84
65
57
60
61
37
70
123
119
148
193
168
136
144
149
186
Long-Term Debt
5
6
21
15
13
36
43
30
32
47
44
37
24
0
25
130
108
79
361
401
262
116
202
228
Deferred Income Tax
0
0
0
0
6
7
8
9
10
11
11
10
8
0
10
12
9
11
9
4
3
4
3
4
Minority Interest
1
1
1
2
2
4
5
5
4
4
4
5
5
0
5
0
1
0
0
0
0
0
0
0
Other Liabilities
3
6
5
4
1
2
2
2
0
0
1
0
0
0
1
4
5
4
0
1
2
4
4
1
Total Liabilities
55
N/A
71
+29%
73
+3%
71
-3%
65
-8%
136
+108%
143
+5%
135
-6%
130
-3%
127
-3%
117
-7%
112
-5%
98
-12%
0
N/A
111
N/A
270
+142%
242
-10%
241
0%
563
+133%
572
+2%
404
-29%
269
-33%
357
+33%
419
+17%
Equity
Common Stock
20
20
20
20
20
20
20
20
20
20
20
20
20
0
20
24
30
36
36
36
46
46
42
42
Retained Earnings
11
18
23
30
34
44
56
69
83
97
102
103
113
0
122
141
171
185
199
144
175
329
307
296
Additional Paid In Capital
1
1
1
1
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Treasury Stock
1
3
3
5
5
9
11
11
11
11
11
11
11
0
0
11
11
11
11
11
11
11
3
3
Other Equity
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1
2
2
7
10
12
19
20
8
8
Total Equity
31
N/A
36
+18%
41
+13%
45
+9%
49
+10%
56
+14%
65
+16%
78
+20%
92
+18%
106
+15%
110
+5%
112
+1%
121
+8%
0
N/A
130
N/A
152
+17%
188
+24%
203
+8%
214
+5%
156
-27%
229
+46%
384
+68%
355
-8%
343
-3%
Total Liabilities & Equity
86
N/A
107
+25%
114
+6%
116
+1%
114
-1%
192
+68%
208
+9%
213
+2%
222
+5%
232
+5%
228
-2%
224
-2%
220
-2%
0
N/A
241
N/A
421
+75%
430
+2%
444
+3%
777
+75%
729
-6%
632
-13%
653
+3%
712
+9%
761
+7%
Shares Outstanding
Common Shares Outstanding
36
35
35
31
34
33
32
32
32
32
32
32
32
0
35
35
29
35
35
35
42
42
42
42

See Also

Summary
IBS intrinsic value, competitors valuation, and company profile.
DCF Valuation
IBS stock valuation using Discount Cash Flow valuation method.
Relative Valuation
IBS stock valuation using valuation multiples.
Wall Street Estimates
IBS price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
IBS stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
ALPHA SPREAD
Follow us
Join more than 316,200+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2026 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.